Indian F&O data, and the evidence about what not to trade · educational
ZYDUSLIFE · Healthcare
1M / 3M / 1Y
+2.4% / +3.6% / +10.4%
Traded value (60d med)
₹129 cr
Days in F&O ban since 2020
0
Futures OI / 1d change
11.0M / +0.0M
ATM implied vol
24% (vs 30% realized)
📜 Results-day history
Typical move 1.6% · up on the day 72% of 18 events · moved 4%+ in 17% · worst -3.9% / best +6.4%
| Reaction day | Move | Open gap | Next 5d | Announced |
|---|
| 2026-07-15 | +2.1% | +1.0% | -2.6% | after close |
| 2026-04-13 | +0.8% | -1.4% | +1.5% | during mkt |
| 2026-01-28 | +0.4% | -0.1% | +0.9% | after close |
| 2025-10-16 | +0.7% | +0.0% | +2.5% | after close |
| 2025-07-18 | -0.8% | +0.4% | +0.1% | after close |
| 2025-04-15 | +1.6% | +2.4% | -1.7% | during mkt |
| 2025-02-06 | +3.2% | +0.7% | -6.5% | after close |
| 2024-11-13 | +1.5% | +0.9% | -2.0% | after close |
Educational data reference: NOT investment advice. Historical statistics do not predict future results. We are not SEBI-registered advisers. All data from NSE public sources; figures may contain errors. Trading, especially leveraged F&O, can cause significant losses.